CD19 and COVID-19: Lymphocytes and the subsets alterations were associated with the clinical characteristics and treatment efficacy of COVID-19, and critically ill patients showed a significant reduction in levels of lymphocytes, monocytes, CD4 + T cells, CD8 + T cells, CD3 cells, CD19 cells, and natural killer (NK) cells (12–14).